secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akebia Therapeutics, Inc. (AKBA)
CIK:        0001517022
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001517022-25-000048
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Akebia amends Medice license to supply vadadustat and grant manufacturing rights
--------------------------------------------------------------------------------

- Amendment #1 to License Agreement signed Nov 12, 2025 with MEDICE Arzneimittel Putter GmbH & Co. KG.
- Akebia agrees to supply vadadustat drug substance under a concurrent supply agreement.
- Medice granted right to manufacture Vafseo tablets using supplied drug substance.
- Any know-how or patent rights from Medice's manufacturing owned by Akebia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517022/000151702225000048/0001517022-25-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517022/000151702225000048/akba-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001517022-25-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer